Apr-16-24 06:21PM
|
|
Apr-11-24 11:38PM
|
|
04:00PM
|
|
Apr-10-24 11:53AM
|
|
09:29AM
|
|
08:31AM |
Loading… |
08:31AM
|
|
08:10AM
|
|
07:00AM
|
|
Apr-09-24 01:15PM
|
|
07:00AM
|
|
Apr-03-24 07:00AM
|
|
Apr-02-24 07:00AM
|
|
Mar-25-24 07:00AM
|
|
Mar-20-24 09:40AM
|
|
Mar-11-24 07:00AM
|
|
04:00PM |
Loading… |
Mar-06-24 04:00PM
|
|
Mar-05-24 04:30PM
|
|
Feb-23-24 06:20AM
|
|
Feb-16-24 07:04PM
|
|
Feb-15-24 05:10PM
|
|
04:00PM
|
|
Feb-01-24 04:01PM
|
|
10:01AM
|
|
Jan-16-24 04:01PM
|
|
Jan-08-24 07:00AM
|
|
Jan-02-24 04:01PM
|
|
Dec-21-23 05:01PM
|
|
Dec-13-23 04:32PM
|
|
Dec-11-23 12:00PM
|
|
Dec-04-23 04:01PM
|
|
04:01PM |
Loading… |
Nov-07-23 04:01PM
|
|
Nov-02-23 09:00AM
|
|
Nov-01-23 04:01PM
|
|
Oct-18-23 09:35AM
|
|
Oct-14-23 06:01AM
|
|
Oct-12-23 05:15PM
|
|
04:01PM
|
|
Oct-11-23 07:09AM
|
|
Oct-05-23 09:35AM
|
|
Oct-04-23 09:35AM
|
|
Sep-28-23 10:00AM
|
|
Sep-20-23 09:30AM
|
|
Sep-15-23 12:00PM
|
|
09:55AM
|
|
Sep-11-23 12:10PM
|
|
Sep-08-23 05:32AM
|
|
Sep-07-23 07:00AM
|
|
Aug-31-23 10:12PM
|
|
04:01PM
|
|
Aug-02-23 05:01AM
|
|
Jul-24-23 09:55AM
|
|
Jul-15-23 08:12AM
|
|
Jul-13-23 05:15PM
|
|
04:01PM
|
|
Jul-11-23 10:00AM
|
|
Jun-29-23 10:00AM
|
|
Jun-14-23 07:00AM
|
|
May-25-23 06:28AM
|
|
May-24-23 09:55AM
|
|
May-09-23 04:01PM
|
|
May-04-23 09:55AM
|
|
Apr-19-23 06:05AM
|
|
Apr-18-23 09:55AM
|
|
Apr-17-23 02:30PM
|
|
Apr-13-23 05:15PM
|
|
04:01PM
|
|
Apr-11-23 04:01PM
|
|
Mar-30-23 10:00AM
|
|
Mar-21-23 10:05AM
|
|
03:49AM
|
|
Mar-20-23 12:17PM
|
|
09:00AM
|
|
08:30AM
|
|
Mar-17-23 09:22AM
|
|
Mar-14-23 04:45PM
|
|
Mar-06-23 04:01PM
|
|
Feb-27-23 11:57AM
|
|
Feb-09-23 05:35PM
|
|
04:15PM
|
|
Feb-08-23 04:01PM
|
|
Jan-09-23 09:55AM
|
|
08:35AM
|
|
Jan-04-23 07:01AM
|
|
Dec-28-22 09:35AM
|
|
Dec-15-22 04:01PM
|
|
Dec-12-22 05:30PM
|
|
08:09AM
|
|
Dec-07-22 04:01PM
|
|
Nov-10-22 09:00AM
|
|
09:00AM
|
|
Nov-04-22 09:55AM
|
|
Nov-03-22 09:00AM
|
|
Nov-02-22 04:01PM
|
|
Oct-26-22 07:00AM
|
|
Oct-19-22 10:57PM
|
|
09:00AM
|
|
Oct-08-22 08:30AM
|
|
Oct-06-22 05:15PM
|
|
04:01PM
|
|
Oct-05-22 08:00AM
|
|
|
|
|
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rape, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
van Houte Hans | Chief Financial Officer | May 02 '24 | Sale | 12.83 | 3,499 | 44,878 | 68,333 | May 02 06:01 PM | Hansen Gwenn | Chief Scientific Officer | Apr 30 '24 | Option Exercise | 0.00 | 5,206 | 0 | 41,608 | Apr 30 06:33 PM | van Houte Hans | Chief Financial Officer | Apr 30 '24 | Option Exercise | 0.00 | 4,886 | 0 | 73,219 | Apr 30 06:33 PM | Ring Christine | Chief Legal Officer | Apr 30 '24 | Option Exercise | 0.00 | 3,924 | 0 | 21,351 | Apr 30 06:33 PM | Hansen Gwenn | Chief Scientific Officer | Apr 30 '24 | Sale | 12.04 | 2,007 | 24,169 | 39,601 | Apr 30 06:33 PM | Ring Christine | Chief Legal Officer | Apr 30 '24 | Sale | 12.04 | 1,513 | 18,220 | 19,838 | Apr 30 06:33 PM | van Houte Hans | Chief Financial Officer | Apr 30 '24 | Sale | 12.04 | 1,387 | 16,703 | 71,832 | Apr 30 06:33 PM | van Houte Hans | Chief Financial Officer | Feb 16 '24 | Sale | 10.02 | 6,812 | 68,223 | 68,333 | Feb 16 07:20 PM | van Houte Hans | Chief Financial Officer | Jan 30 '24 | Option Exercise | 0.00 | 4,886 | 0 | 76,816 | Jan 30 06:53 PM | Hansen Gwenn | Chief Scientific Officer | Jan 30 '24 | Option Exercise | 0.00 | 5,207 | 0 | 38,736 | Jan 30 06:52 PM | Ring Christine | Chief Legal Officer | Jan 30 '24 | Option Exercise | 0.00 | 3,924 | 0 | 19,187 | Jan 30 06:52 PM | Hansen Gwenn | Chief Scientific Officer | Jan 30 '24 | Sale | 7.99 | 2,334 | 18,649 | 36,402 | Jan 30 06:52 PM | Ring Christine | Chief Legal Officer | Jan 30 '24 | Sale | 7.99 | 1,760 | 14,063 | 17,427 | Jan 30 06:52 PM | van Houte Hans | Chief Financial Officer | Jan 30 '24 | Sale | 7.99 | 1,671 | 13,352 | 75,145 | Jan 30 06:53 PM | van Houte Hans | Chief Financial Officer | Dec 20 '23 | Sale | 10.00 | 3,541 | 35,421 | 71,930 | Dec 21 05:19 PM | van Houte Hans | Chief Financial Officer | Dec 19 '23 | Sale | 10.00 | 10,906 | 109,093 | 75,471 | Dec 20 04:55 PM | Hansen Gwenn | Chief Scientific Officer | Oct 31 '23 | Sale | 5.20 | 1,633 | 8,487 | 33,529 | Nov 01 04:40 PM | Ring Christine | Chief Legal Officer | Oct 31 '23 | Sale | 5.20 | 1,232 | 6,403 | 15,263 | Nov 01 04:40 PM | van Houte Hans | Chief Financial Officer | Oct 31 '23 | Sale | 5.20 | 1,080 | 5,613 | 86,377 | Nov 01 04:41 PM | van Houte Hans | Chief Financial Officer | Oct 30 '23 | Option Exercise | 0.00 | 4,886 | 0 | 87,457 | Nov 01 04:41 PM | Hansen Gwenn | Chief Scientific Officer | Oct 30 '23 | Option Exercise | 0.00 | 5,207 | 0 | 35,162 | Nov 01 04:40 PM | Ring Christine | Chief Legal Officer | Oct 30 '23 | Option Exercise | 0.00 | 3,924 | 0 | 16,495 | Nov 01 04:40 PM | Hansen Gwenn | Chief Scientific Officer | Jul 31 '23 | Sale | 9.65 | 1,884 | 18,189 | 29,955 | Aug 01 04:26 PM | Ring Christine | General Counsel | Jul 31 '23 | Sale | 9.65 | 1,420 | 13,710 | 12,544 | Aug 01 04:27 PM | van Houte Hans | Chief Financial Officer | Jul 31 '23 | Sale | 9.65 | 1,245 | 12,020 | 82,571 | Aug 01 04:28 PM | van Houte Hans | Chief Financial Officer | Jul 30 '23 | Option Exercise | 0.00 | 4,886 | 0 | 83,816 | Aug 01 04:28 PM | Ring Christine | General Counsel | Jul 30 '23 | Option Exercise | 0.00 | 3,924 | 0 | 13,964 | Aug 01 04:27 PM | Hansen Gwenn | Chief Scientific Officer | Jul 30 '23 | Option Exercise | 0.00 | 5,207 | 0 | 31,839 | Aug 01 04:26 PM |
|